These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 30921254)

  • 61. Addition of a H2 receptor antagonist to PPI improves acid control and decreases nocturnal acid breakthrough.
    Mainie I; Tutuian R; Castell DO
    J Clin Gastroenterol; 2008 Jul; 42(6):676-9. PubMed ID: 18496394
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Long-term benefit of transoral incisionless fundoplication using the esophyx device for the management of gastroesophageal reflux disease responsive to medical therapy.
    Stefanidis G; Viazis N; Kotsikoros N; Tsoukalas N; Lala E; Theocharis L; Fassaris A; Manolakopoulos S
    Dis Esophagus; 2017 Feb; 30(3):1-8. PubMed ID: 27868281
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Pattern of esophageal eosinophilic infiltration in patients with achalasia and response to Heller myotomy and Dor fundoplication.
    Cools-Lartigue J; Chang SY; Mckendy K; Mayrand S; Marcus V; Fried GM; Ferri LE
    Dis Esophagus; 2013; 26(8):766-75. PubMed ID: 22891632
    [TBL] [Abstract][Full Text] [Related]  

  • 64. The changing role of H2-receptor antagonists in acid-related diseases.
    Lamers CB
    Eur J Gastroenterol Hepatol; 1996 Oct; 8 Suppl 1():S3-7. PubMed ID: 8930573
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Acid suppressive agents and risk of Mycobacterium tuberculosis: case-control study.
    Hsu WH; Kuo CH; Wang SS; Lu CY; Liu CJ; Chuah SK; Kuo FC; Chen YH; Huang YB; Hou MF; Wu DC; Hu HM
    BMC Gastroenterol; 2014 May; 14():91. PubMed ID: 24884853
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Management of Gastroesophageal Reflux Disease.
    Gyawali CP; Fass R
    Gastroenterology; 2018 Jan; 154(2):302-318. PubMed ID: 28827081
    [TBL] [Abstract][Full Text] [Related]  

  • 67. The effects of proton pump inhibitors on autonomic tone in patients with erosive and non-erosive esophagitis.
    Jones EL; Perring S; Khattab A; Allenby-Smith O
    Neurogastroenterol Motil; 2016 May; 28(5):659-64. PubMed ID: 26748487
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Clinical Outcomes of Acid Suppressive Therapy Use in Hematology/Oncology Patients at an Academic Medical Center.
    McCaleb RV; Gandhi AS; Clark SM; Clemmons AB
    Ann Pharmacother; 2016 Jul; 50(7):541-7. PubMed ID: 27091869
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Endoscopic assessment of children with esophageal atresia: Lack of relationship of esophagitis and esophageal metaplasia to symptomatology.
    Castilloux J; Bouron-Dal Soglio D; Faure C
    Can J Gastroenterol; 2010 May; 24(5):312-6. PubMed ID: 20485706
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Predictors of response to proton pump inhibitor therapy among children with significant esophageal eosinophilia.
    Dranove JE; Horn DS; Davis MA; Kernek KM; Gupta SK
    J Pediatr; 2009 Jan; 154(1):96-100. PubMed ID: 18783791
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Therapeutic approaches to healing esophagitis.
    Boyce HW
    Am J Gastroenterol; 1997 Apr; 92(4 Suppl):22S-27S; discussion 27S-29S. PubMed ID: 9127623
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Long gap esophageal atresia and esophageal replacement: moving toward a separation?
    Bagolan P; Iacobelli Bd Bd; De Angelis P; di Abriola GF; Laviani R; Trucchi A; Orzalesi M; Dall'Oglio L
    J Pediatr Surg; 2004 Jul; 39(7):1084-90. PubMed ID: 15213904
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Use of acid suppressive therapy more than 10 years after the endoscopic diagnosis of reflux esophagitis with specific emphasis to trademark and generic proton pump inhibitors.
    Dackus GH; Loffeld SM; Loffeld RJ
    J Gastroenterol Hepatol; 2012 Feb; 27(2):368-71. PubMed ID: 21777284
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Long-Term Outcomes of Patients with Tracheoesophageal Fistula/Esophageal Atresia: Survey Results from Tracheoesophageal Fistula/Esophageal Atresia Online Communities.
    Acher CW; Ostlie DJ; Leys CM; Struckmeyer S; Parker M; Nichol PF
    Eur J Pediatr Surg; 2016 Dec; 26(6):476-480. PubMed ID: 26692337
    [No Abstract]   [Full Text] [Related]  

  • 75. Age-based differences in the diagnosis and management of esophageal eosinophilia.
    Rassbach W; Rubenstein JH; Elkins M; DeMatos V; Greenson JK; Greenhawt M
    J Allergy Clin Immunol Pract; 2015; 3(1):81-87.e1. PubMed ID: 25577623
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Omeprazole maintenance therapy for gastroesophageal reflux disease after failure of fundoplication.
    Pashankar D; Blair GK; Israel DM
    J Pediatr Gastroenterol Nutr; 2001 Feb; 32(2):145-9. PubMed ID: 11321383
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Chronic esophagitis and gastric metaplasia are frequent late complications of esophageal atresia.
    Lindahl H; Rintala R; Sariola H
    J Pediatr Surg; 1993 Sep; 28(9):1178-80. PubMed ID: 8308687
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Evaluation of Gastroesophageal Reflux by Combined Multichannel Intraluminal Impedance and pH Monitoring and Esophageal Motility Patterns in Children with Esophageal Atresia.
    Tong S; Mallitt KA; Krishnan U
    Eur J Pediatr Surg; 2016 Aug; 26(4):322-31. PubMed ID: 26445355
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Comparison of clinical features in patients with eosinophilic esophagitis living in an urban and rural environment.
    Lee YJ; Redd M; Bayman L; Frederickson N; Valestin J; Schey R
    Dis Esophagus; 2015 Jan; 28(1):19-24. PubMed ID: 24382218
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Medical treatments in the short-term management of reflux esophagitis.
    Guirguis-Blake J
    Am Fam Physician; 2008 Mar; 77(5):620. PubMed ID: 18350759
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.